Company intelligence / Profile preview

MetaTech

New Taipei, New Taipei City, Taiwanmetatech-official.co ↗

Ownership: Private
Development stage: Other

Overview

MetaTech has pioneered the introduction of cell sheet technology for regenerative medical treatments in Taiwan through a partnership with Japan’s CellSeed, focusing on esophageal and cartilage regeneration. The company has received government support to accelerate clinical trials and is building GMP-compliant facilities for advanced cell therapy manufacturing. No published pivotal or late-stage results are available.

Therapeutic areas: GastroenterologyRheumatology
Modalities: Cell therapyRegenerative medicine technologies
Industry: Biotech

Partnerships

CellSeed Co., Ltd. (Japan)Hitachi Group collaboration via LOCUS CELL CO., LTD.

Beyond the preview

Go deeper on MetaTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MetaTech.

Explore the full profile